Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,729 | -291,754 | -232,884 | -146,234 | -96,084 |
| Depreciation Amortization | 949 | 3,699 | 2,649 | 1,654 | 767 |
| Accounts receivable | 8,529 | 13,052 | 31,849 | 7,327 | 5,991 |
| Accounts payable and accrued liabilities | 11,739 | -4,548 | -6,149 | 1,423 | 4,757 |
| Other Working Capital | -9,346 | -76,754 | -22,790 | -32,117 | -17,117 |
| Other Operating Activity | -4,874 | 115,181 | 86,154 | 63,865 | 47,641 |
| Operating Cash Flow | $-68,732 | $-241,124 | $-141,171 | $-104,082 | $-54,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,952 | -1,495 | -615 |
| Purchase Of Investment | N/A | -127,382 | 0 | 0 | N/A |
| Sale Of Investment | 17,500 | N/A | 0 | 0 | 0 |
| Other Investing Activity | 26 | -39,468 | -35,000 | -35,000 | -35,000 |
| Investing Cash Flow | $17,526 | $-166,850 | $-36,952 | $-36,495 | $-35,615 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 240,679 | 240,679 | 191,190 | 191,190 |
| Debt Repayment | N/A | -190,750 | -190,750 | -190,750 | -190,750 |
| Common Stock Issued | 6,938 | 7,049 | 631 | 552 | 544 |
| Common Stock Repurchased | N/A | 2,320 | 1,655 | 1,655 | N/A |
| Other Financing Activity | -3,134 | -4,972 | -4,482 | -3,781 | -2,839 |
| Financing Cash Flow | $3,804 | $54,326 | $47,733 | $-1,134 | $-1,855 |
| Beginning Cash Position | 63,987 | 417,635 | 417,635 | 417,635 | 417,635 |
| End Cash Position | 16,585 | 63,987 | 287,245 | 275,924 | 326,120 |
| Net Cash Flow | $-47,402 | $-353,648 | $-130,390 | $-141,711 | $-91,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,732 | -241,124 | -141,171 | -104,082 | -54,045 |
| Capital Expenditure | N/A | N/A | -1,952 | -1,495 | -615 |
| Free Cash Flow | -68,732 | -241,124 | -143,123 | -105,577 | -54,660 |